| Name
|
Cetrorelix
|
| Code
|
[120287-85-6]
|
| The alias
|
Cetrorelix
|
| Sequence (single letter abbreviation)
|
Ac-D-2-Nal-4-chloro-D-F-beta-(3-pyridyl)-D-ASY-D-Cit-LRPa-NH2
|
| Sequence (three-letter abbreviation)
|
Ac-D-2-Nal-4-chloro-D-Phe-beta-(3-pyridyl)-D-Ala-Ser-Tyr-D-Cit-Leu-Arg-Pro-D-Ala-NH2?(acetate salt)
|
| A basic description
|
GHK possesses a high affinity for copper(II) ions, with which it spontaneously forms a complex (GHK-Cu). This growth-modulating plasma tripeptide, when added at nanomolar concentrations to a wide group of cultured systems, produces a disparate set of responses ranging from the stimulation of growth and differentiation to outright toxicity. It may function by facilitating copper uptake into cells. GHK-Cu accelerates wound healing. The palmitoylated peptide is marketed as a cosmetic ingredient under the trade name Biopeptide CL. CAS Number (net): 49557-75-7.Growth-modulating plasma tripeptide that produces a variety of responses ranging from the stimulation of growth and differentiation of outright toxicity when added at nanomolar concentrations to cultured systems. It also serves as a facilitator of copper uptake into cells, which can accelerate wound healing.
|
| solubility
|
|
| The molecular weight
|
1431.06
|
| Chemical formula
|
C70H92Cl1N17O14
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
T.Reissmann et al., Hum. Reprod. Update, 6, 322 (2000)
G.Emons et al., Endocr. Relat. Cancer, 10, 291 (2003)
D.B.Shapiro and D.Mitchell-Leef, Minerva Ginecol., 55, 373 (2003)
C.Gründker et al., Eur. J. Endocrinol., 151, 141 (2004)
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
|